Cargando…
The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
BACKGROUND: Anti-cancer drugs access solid tumors via blood vessels, and must penetrate tumor tissue to reach all cancer cells. Previous studies have demonstrated steep gradients of decreasing doxorubicin fluorescence with increasing distance from blood vessels, such that many tumor cells are not ex...
Autores principales: | Patel, Krupa J, Tannock, Ian F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770566/ https://www.ncbi.nlm.nih.gov/pubmed/19807929 http://dx.doi.org/10.1186/1471-2407-9-356 |
Ejemplares similares
-
Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
por: Yu, Man, et al.
Publicado: (2015) -
The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
por: Gao, Wei, et al.
Publicado: (2014) -
Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
por: Kim, Tae Hwan, et al.
Publicado: (2018) -
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
por: Schuurhuis, G. J., et al.
Publicado: (1991) -
Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression
por: Lu, Yong-lin, et al.
Publicado: (2019)